No Data
No Data
Galera Therapeutics GAAP EPS of -$0.10
Express News | As Of December 31, 2023, Galera Had Cash And Cash Equivalents Of $18.3M Which Is Expected To Provide Cash Runway Into Q2 Of 2025
Express News | Galera Therapeutics Q4 EPS $(0.10) Beats $(0.35) Estimate
Galera Therapeutics 4Q Loss/Shr 10c >GRTX
Galera Therapeutics 4Q Loss/Shr 10c >GRTX
Express News | On March 26, Galera Therapeutics Received Letter From Nasdaq Staff Indicating That Company Has Not Regained Compliance With Minimum Market Value Of Listed Securities-8K
Galera Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inte
No Data
TrytosaveabitOP : As Of December 31, 2023, Galera Had Cash And Cash Equivalents Of $18.3M Which Is Expected To Provide Cash Runway Into Q2 Of 2025
Wee newbie : any pt from u?